Home › NDC Lookup › RxCUI directory › RxCUI 794641

Lubiprostone 0.008 MG Oral Capsule [Amitiza] — RxCUI 794641

Name: Lubiprostone 0.008 MG Oral Capsule [Amitiza] (RxCUI 794641)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 794641 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI794641

Official nameLubiprostone 0.008 MG Oral Capsule [Amitiza]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAmitiza 8 MCG Oral Capsule; Amitiza 0.008 MG Oral Capsule

FDA products mapped4

Package NDCs mapped3

Reported Medicaid activity (SDUD)2,249 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lubiprostone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats long-lasting constipation with no known cause in adults. It also treats constipation caused by opioid pain medicines in adults with chronic non-cancer pain. In women 18 a...
Take your capsule by mouth with food and water, and swallow it whole. Don't chew or break it. It's usually taken twice a day, but follow your prescriber's directions for your dose.
Nausea is the most common side effect, and taking it with food may help. Diarrhea, headache, belly pain, bloating, and gas can also happen. Call your doctor if the diarrhea is seve...
Call if you faint or feel very lightheaded, or if you get chest tightness or trouble breathing. These can happen within an hour of a dose and may come back with later doses. Severe...

📖 Read our full Lubiprostone guide →

🕸️ Concept Web — How Lubiprostone 0.008 MG Oral Capsule [Amitiza] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Lubiprostone 0.008 MG Oral Capsule [Amitiza] RxCUI 794641 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Lubiprostone 623033 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Amitiza 615205 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Lubiprostone Oral Capsule 616577 SCDF
- Lubiprostone Oral Product 1163872 SCDG
- Lubiprostone Pill 1163873 SCDG
- Lubiprostone Oral Capsule [Amitiza] 617767 SBDF
- Amitiza Oral Product 1172836 SBDG
- Amitiza Pill 1172837 SBDG
- Oral Capsule 316965 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Lubiprostone 0.008 MG Oral Capsule 794639 SCD
- Lubiprostone 0.008 MG 794638 SCDC
- Lubiprostone 0.008 MG [Amitiza] 794640 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Lubiprostone 0.008 MG Oral Capsule SCD · 794639
Lubiprostone 0.008 MG SCDC · 794638
Lubiprostone Oral Capsule SCDF · 616577
Lubiprostone Oral Product SCDG · 1163872
Lubiprostone Pill SCDG · 1163873

Brand-Name Concepts

Lubiprostone 0.008 MG [Amitiza] SBDC · 794640
Lubiprostone Oral Capsule [Amitiza] SBDF · 617767
Amitiza Oral Product SBDG · 1172836
Amitiza Pill SBDG · 1172837
Amitiza BN · 615205

📦 FDA Products & Package NDCs

4 products · 3 package NDCs

3 package NDCs map to RxCUI 794641 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
23635-0508-60	60 CAPSULE, GELATIN COATED in 1 BOTTLE (23635-508-60)	Amitiza	SpecGx LLC	2024-04-01
23635-0524-60	60 CAPSULE, GELATIN COATED in 1 BOTTLE (23635-524-60)	Amitiza	SpecGx LLC	2024-04-01
64764-0240-60	60 CAPSULE, GELATIN COATED in 1 BOTTLE (64764-240-60)	Amitiza	Takeda Pharmaceuticals America, Inc.	2006-01-31

Observed labelers: SpecGx LLC (2) · Takeda Pharmaceuticals America, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.